Roadshow
Biomarker Analyzer INB-D200/INB-D8
INB-D200 and INB-D8 are light-sensing Biomarker Analyzer based on our unique & patented FOPPR™ Technology (Fiber Optic Particle Plasmon Resonance), which takes advantage of multiple total internal reflections in an optical fiber coated with nano gold particles to supply scientists label-free ultrasensitive detections of up to 5 orders linear range within minutes. The easy-to-use instrument design offers self-referencing during real-time detection and it can reduce thermal or bulk-composition effects to further compensate non-specific adsorption of biomolecules in complex samples. Our platform is the best choice for Developments of Antibodies, Vaccines and other Pharmaceutical products, as well as clinical diagnostics and a variety of other demanding scientific applications.
Our Light-Sensing Protein & Nucleic Acid Biomarker Portable Platform utilizes patented Fiber Optic Particle Plasmon Resonance (FOPPR) and IN-Chip (auto-flowing microfluidic chip) platform technology for the life science research and in vitro diagnostics markets, enabling molecule measurement of proteins, nucleic acids and cells. The technology of combining FOPPR & IN-Chip can shorten the time consumed in detecting biomarker at the laboratory from three hours to just several minutes and enhance the detection sensitivity (fg/ml) of devices which allows our product to gather data comparable to top diagnostic laboratories. With our cutting-edge-light-sensing platform to detect otherwise under-detectable biomarkers for diseases, we aspire to revolutionize traditional immunoassays and analytics for a more efficient healthcare solutions.
Thus, our technology can complete on-site detection effectively to assist the medical personnel in speeding up their diagnosis.
- Established 2016
- Company INSTANT NANOBIOSENSORS CO.,LTD
- Telephone +886-2-26538655
- Address Rm.C328, 3rd Floor, No. 99, Ln. 130, Sec. 1, Academia Rd., Nangang Dist. Taipei City 11571, Taiwan
Instant NanoBiosensors focused mainly on the development of the Light-Sensing Protein & Nucleic Acid Biomarker Portable Platform that utilizes FOPPR (Fiber Optic Particle Plasmon Resonance) technology to revolutionize traditional immunoassays and analysis for a more efficient healthcare ecosystem. We believed that the integration of nanotechnology into biosensors will benefit the world by moving bioanalysis from laboratory to any point of use. The vision of our will be the pioneer and leader in portable biosensors platforms for protein and nucleic acid biomarkers in five years. In May 2019, we launched Light Sensing Biomarker Analyzer, which won its first overseas order from Brigham and Women's Hospital (BWH), a teaching hospital of Harvard Medical School and have been working with BWH in clinical studies. In 2020, we were one the 12 innovative young companies for worldwide strategic collaboration selected by Merck KGaA because of our unique fiber optic microfluidics nano-chip technology. As we can analyze -- with three easy steps -- proteins and nucleic acids like top laboratories, we hope through our system we can realize our dream of “immediate care” to make health care quicker, cheaper, and more comfortable without sacrificing quality.